The 411 on Obesity

Novo Nordisk

Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.

Episodes

  1. 06/30/2025

    Experts Answer Your Top Questions About a GLP-1 RA Obesity Treatment

    Join panelists Donna Ryan, MD, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, Ethan Lazarus, MD, Director of Clinical Nutrition Center in Denver, Colorado, and Lawrence Herman, DMSc PA-C, Adjunct Professor at the University of Lynchburg and President of Palantir Healthcare, LLC, in Greenville, South Carolina, as they address frequently asked questions about the use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) in appropriate adults with obesity or overweight and at least one weight-related comorbidity. The discussion includes commonly asked questions about trial design from relevant chronic weight- management and cardiovascular outcomes trials, efficacy and safety data, and practical guidance on dosing and administration. Please see Prescribing Information, including boxed warning. This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only. The moderator and expert discussants were compensated by Novo Nordisk for their participation in this podcast. Faculty Presenters: Donna Ryan, MD Professor Emerita Pennington Biomedical Research Center Baton Rouge, LA Ethan Lazarus, MD, MFOMA Clinical Nutrition Center Anschutz Medical Center Denver, CO Lawrence Herman, DMSc, MPA, PA-C Palantir Healthcare, LLC Boiling Springs, South Carolina Doctor of Medical Science Program, University of Lynchburg Lynchburg, Virginia

    44 min

  2. 06/30/2025

    Is It Time for an Evolution of Clinical Guidelines for Obesity? A Review of Recent Data

    Join Donna Ryan, MD, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana; Deborah Horn, DO, Associate Professor at the University of Texas Center McGovern Medical School and Medical Director of the Center for Obesity Medicine and Metabolic Performance in Houston, Texas; and Matthew Budoff, MD, Professor of Medicine In-Residence at the David Geffen School of Medicine and Endowed Chair of Preventive Cardiology at the Lundquist Institute for Biomedical Innovation at Harbor- UCLA Medical Center in Los Angeles, California, for a conversation about the evolution of anti-obesity medicine and associated clinical practice guidelines. The panel will also discuss clinical data from a trial that evaluated a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for chronic weight management in adult patients with obesity or overweight with a weight-related comorbidity. Data on the effects of the GLP-1 RA on cardiometabolic risk factors, as observed in this trial, will also be presented. Lastly, the panel will review data from a cardiovascular outcomes trial which assessed the effect of the GLP-1 RA on reducing the risk of major adverse cardiovascular events (MACE) in patients with obesity or overweight and established cardiovascular disease. Please see Prescribing Information, including boxed warning. This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only. The moderator and expert discussants were compensated by Novo Nordisk for their participation in this podcast. Faculty Presenters: Donna Ryan, MD Professor Emerita Pennington Biomedical Research Center Baton Rouge, LA Deborah Bade Horn, DO MPH MFOMA Medical Director University of Texas, Center for Obesity Medicine and Metabolic Performance (COMMP) Associate Professor University of Texas McGovern Medical School, Department of Surgery Program Director UT Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolic Performance Diplomate American Board of Obesity Medicine Houston, TX Matthew Jay Budoff, MD Professor of Medicine University of California Los Angeles Endowed Chair of Preventative Cardiology Lundquist Institute Torrance, CA

    42 min

  3. 06/30/2025

    Are You Taking a Patient-Centered Approach to Obesity Management?

    Join a panel of experts including Donna Ryan, MD, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana; Anthony Auriemma, MD, Medical Director at Ascension Illinois Medical Group Weight Loss Solutions in Schaumburg, Illinois; and Dana Trippi, DO, Founder and Chief Medical Officer at Premier Physicians Weight Loss and Wellness in Las Vegas, Nevada, for a discussion on anti-obesity medicine and the need for clinicians to adopt a comprehensive, individualized approach to patient care. The panel will also review data from a cardiovascular outcomes trial of a glucagon- like peptide-1 receptor agonist (GLP-1 RA) in adults with obesity or overweight and established cardiovascular disease. Additionally, results from along-term weight management trial will be reviewed, including data on sustained body weight reduction at 2 years, as well as effects on cardiometabolic risk factors. Please see Prescribing Information, including boxed warning. This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only. The moderator and expert discussants were compensated by Novo Nordisk for their participation in this podcast. Faculty Presenters: Donna Ryan, MD Professor Emerita Pennington Biomedical Research Center Baton Rouge, LA Anthony Auriemma, MD, JD, FOMA Market Medical Director and Vice President of Clinical Partnerships knownwell Schaumburg, IL Dana Trippi, D.O., ABEM, DABOM Founder/Chief Medical Officer Premier Physicians Weight Loss &Wellness Las Vegas, NV

    43 min

  4. 03/19/2025

    The Growing Epidemic: Raising Awareness About Adolescent Obesity

    Join a panel of obesity experts, including Dr Donna Ryan, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana; Dr Angela Fitch, Associate Director of the Massachusetts General Hospital Weight Center and faculty at Harvard Medical School in Boston, Massachusetts; and Dr Jennifer Paisley, an internal medicine and pediatric physician at St. Elizabeth Healthcare in Lawrenceburg, Indiana, as they dive into the complex issue of adolescent obesity. The panel will discuss the importance of disease awareness and address the stigma surrounding adolescent obesity. They will also discuss the current clinical practice guidelines regarding assessment and treatment of obesity in adolescents aged 12 years and older and evaluate the efficacy and safety of a pharmacotherapy treatment option for chronic weight management in adolescents aged 12 years and older with obesity. Please see Prescribing Information, including boxed warning. This program is intended for clinicians in the US only. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only. The moderator and expert discussants were compensated for their participation in this podcast. Faculty Presenters: Donna Ryan, MD Professor Emerita Pennington Biomedical Research Center Baton Rouge, LA Angela Fitch, MD, FACP, FOMA President Obesity Medicine Association Chief Medical Officer and Co-Founder Knownwell Boston, MA Dr. Jennifer Paisley Internal Medicine & Pediatric Physician St. Elizabeth Physicians Group Lawrenceburg, IN

    43 min

  5. 03/19/2025

    Navigating Opportunities to Address CV Risk & Weight in Appropriate Patients

    Join a panel of cardiometabolic experts including, Dr Donna Ryan, Professor Emerita at the Pennington Biomedical Research Center in Baton Rouge, Louisiana, Dr Sanjay Rajagopalan, Chief of Cardiovascular Medicine at University Hospitals Harrington Heart and Vascular Institute, and Professor of Medicine at Case Western Reserve School of Medicine in Cleveland, OH and Dr Deborah Horn, Medical Director of the Center for Obesity Medicine and Metabolic Performance at the University of Texas, as they discuss the link between obesity and cardiovascular risk, and the urgent need to address CV risk as well as weight in people with obesity or overweight. The panel will then review the efficacy and safety data from a cardiovascular outcomes trial (CVOT). Please see Prescribing Information, including boxed warning. This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only. The moderator and expert discussants were compensated for their participation in this podcast. Faculty Presenters: Donna Ryan, MD Professor Emerita Pennington Biomedical Research Center Baton Rouge, LA Sanjay Rajagopalan, MD, MBA, FACC, FAHA  Chief, Cardiovascular Medicine and Chief Academic and Scientific Officer University Hospitals, Harrington Heart & Vascular Institute Cleveland, OH Deborah Bade Horn DO MPH MFOMA Medical Director, University of Texas, Center for Obesity Medicine and Metabolic Performance (COMMP) Associate Professor, University of Texas McGovern Medical School, Department of Surgery Program Director, UT Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolic Performance  Diplomate, American Board of Obesity Medicine Houston, TX

    32 min

  6. 03/19/2025

    Treating Obesity with Pharmacotherapy: Exploring Long-term Weight Loss

    Join experts in obesity Dr Donna Ryan (Professor Emerita at Pennington Biomedical Research Center, in Baton Rouge, Louisiana), Dr Jeremy McConnell (Chief Executive Officer and Founder of Florida Sleep Specialists and Discover Health Obesity Medicine Clinic, both in Bradenton, Florida), and Dr Angela Fitch (President of the Obesity Medicine Association and Co-Founder and Chief Medical Officer of knownwell, in Needham, Massachusetts) as they share their insights on the challenges of obesity and its association with certain weight-related comorbidities. The panel will also discuss the efficacy and safety of a pharmacotherapy for chronic weight management in adult patients with obesity or overweight with a weight-related comorbidity, highlighting the role of pharmacotherapy in long-term weight loss at 2 years in addition to lifestyle intervention. Please see Prescribing Information, including boxed warning. This program is intended for clinicians. The information presented is aligned with the views and opinions of the speakers and is sponsored by Novo Nordisk. This podcast is not to be used as medical advice and is intended for educational purposes only. The moderator and expert discussants were compensated for their participation in this podcast. Faculty Presenters: Donna Ryan, MD Professor Emerita Pennington Biomedical Research Center Baton Rouge, LA Jeremy McConnell, MD, FOMA, Dipl. ABOM Obesity and Sleep Medicine Physician Florida Sleep Specialists & Discover Health Bradenton, FL Angela Fitch, MD, FACP, FOMA President Obesity Medicine Association Chief Medical Officer and Co-Founder knownwell Boston, MA

    39 min
  • 6 Episodes

About

Join Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center at Baton Rouge in Louisiana, alongside leading experts in the field of obesity and weight management, as they dive into challenges and strategies for the treatment of obesity in this podcast series. Discussion topics will include when to add an anti-obesity medication (AOM) to treat obesity, establishing the efficacy and safety of an AOM, sustaining weight loss, as well as dosing and administration information.

Information

  • Creator
    Novo Nordisk
  • Years Active
    2024 - 2025
  • Episodes
    6
  • Rating
    Clean
  • Copyright
    © 2023 Novo Nordisk
  • Show Website
    The 411 on Obesity